Clinical Trial Update: A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a mixture of antioxidants for adrenomyeloneuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenomyeloneuropathy

Snippet

Sponsor: Pujol, Aurora, M.D. | Conditions: Adrenomyeloneuropathy | Phase 2 | Status: COMPLETED